|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
52,907,000 |
Market
Cap: |
N/A |
Last
Volume: |
678,324 |
Avg
Vol: |
306,439 |
52
Week Range: |
$11.15 - $11.15 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) ![](../../images/information.jpg) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-17 |
2023-12-15 |
2023-06-16 |
2022-06-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Cavazza Paolo |
officerTitle |
|
2005-12-20 |
4 |
B |
$0.00 |
$75,520 |
I/I |
34,642 |
536,441 |
1.5 |
- |
|
Cavazza Paolo |
officerTitle |
|
2005-12-20 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Cavazza Paolo |
officerTitle |
|
2005-12-19 |
4 |
B |
$2.00 |
$181,163 |
I/I |
90,730 |
501,799 |
1.5 |
- |
|
Defiante Farmaceutica Lda |
officerTitle |
|
2005-12-16 |
4 |
OE |
$5.00 |
$25,000 |
I/I |
5,000 |
6,068,011 |
|
- |
|
Cavazza Claudio |
officerTitle |
|
2005-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
394,615 |
|
- |
|
Cavazza Claudio |
officerTitle |
|
2005-12-16 |
4 |
OE |
$5.00 |
$25,000 |
I/I |
5,000 |
6,068,011 |
|
- |
|
Cavazza Paolo |
officerTitle |
|
2005-12-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
572,815 |
|
- |
|
Cavazza Paolo |
officerTitle |
|
2005-12-16 |
4 |
OE |
$5.00 |
$25,000 |
I/I |
5,000 |
6,068,011 |
|
- |
|
Baxter John D |
Director |
|
2005-08-11 |
4 |
AS |
$6.00 |
$48,000 |
I/I |
(8,000) |
361,492 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
0 |
394,615 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-17 |
4 |
OE |
$5.00 |
$6,315,500 |
I/I |
1,263,100 |
6,063,011 |
|
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-17 |
4 |
B |
$4.79 |
$644,682 |
I/I |
134,237 |
4,799,911 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-17 |
4 |
B |
$0.00 |
$644,682 |
I/I |
134,237 |
501,069 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-17 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-17 |
4 |
OE |
$5.00 |
$6,315,500 |
I/I |
1,263,100 |
6,063,011 |
|
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-06-17 |
4 |
OE |
$5.00 |
$6,180,500 |
I/I |
1,236,100 |
6,063,011 |
|
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-06-17 |
4 |
B |
$4.79 |
$644,682 |
I/I |
134,237 |
4,799,911 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-16 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
394,615 |
2.37 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-16 |
4 |
B |
$4.60 |
$108,155 |
I/I |
23,516 |
4,665,674 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-16 |
4 |
B |
$0.00 |
$108,155 |
I/I |
23,516 |
501,069 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-16 |
4 |
B |
$0.00 |
$0 |
D/D |
0 |
572,815 |
2.37 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-06-16 |
4 |
B |
$4.60 |
$108,155 |
I/I |
23,516 |
4,665,674 |
1.5 |
- |
|
Cavazza Claudio |
10% Owner |
|
2005-06-15 |
4 |
B |
$4.49 |
$224,360 |
I/I |
50,000 |
4,642,158 |
1.5 |
- |
|
Cavazza Paolo |
10% Owner |
|
2005-06-15 |
4 |
B |
$4.40 |
$444,360 |
I/I |
100,000 |
548,152 |
1.5 |
- |
|
Defiante Farmaceutica Lda |
10% Owner |
|
2005-06-15 |
4 |
B |
$4.49 |
$224,360 |
I/I |
50,000 |
4,642,158 |
1.5 |
- |
|
565 Records found
|
|
Page 18 of 23 |
|
|